TargetCOPD评分:预测未诊断慢阻肺风险的开发与验证
本研究基于英国基层医疗电子健康记录开发并外部验证了TargetCOPD风险评分,用于识别未诊断的症状性慢阻肺。评分包含年龄、吸烟状态、呼吸困难、沙丁胺醇处方和抗生素处方,c统计量为0.74(95%CI 0.68-0.80),切点≥7.5%时敏感性和特异性均为68.8%。该评分可整合入临床信息系统以辅助基层医生靶向病例发现。
要点
- TargetCOPD评分基于年龄、吸烟、呼吸困难、沙丁胺醇和抗生素处方五项常规数据。
- 外部验证c统计量0.74,切点≥7.5%时敏感性和特异性均为68.8%。
- 该评分可整合入电子健康记录系统,辅助基层医生靶向筛查未诊断慢阻肺。
核心结论
- 基于基层医疗电子健康记录的新型风险评分可识别未诊断的症状性慢阻肺高危患者。
- 该评分可整合入临床信息系统,帮助基层医生靶向病例发现。
研究设计与样本
- 研究为实用性整群随机对照病例发现试验的回顾性队列分析,地点在英国西米德兰兹。
- 参与者为40-79岁、既往无慢阻肺诊断者,接受邮寄或机会性筛查问卷。
- 有慢性呼吸道症状者接受肺功能检查;慢阻肺定义为有相关症状且支气管舒张后FEV1/FVC低于正常下限。
- 使用2398名返回邮寄问卷参与者的电子健康记录数据,通过逻辑回归开发风险评分。
- 在1097名返回机会性问卷的参与者中进行外部验证,计算c统计量及切点的敏感性和特异性。
主要发现
- 风险评分包含年龄、吸烟状态、呼吸困难、沙丁胺醇处方和抗生素处方,可区分有无未诊断慢阻肺(c统计量0.74,95%CI 0.68-0.80)。
- 切点≥7.5%预测风险时,敏感性为68.8%(95%CI 57.3-78.9%),特异性为68.8%(95%CI 65.8-71.6%)。
关键数值与推荐
- 风险评分变量:年龄、吸烟状态、呼吸困难、沙丁胺醇处方、抗生素处方。
- 区分度:c统计量0.74(95%CI 0.68-0.80)。
- 切点≥7.5%预测风险:敏感性68.8%(95%CI 57.3-78.9%),特异性68.8%(95%CI 65.8-71.6%)。
临床怎么用
- 基层医生可利用电子健康记录中的年龄、吸烟状态、呼吸困难、沙丁胺醇和抗生素处方信息计算TargetCOPD评分。
- 对评分≥7.5%预测风险的患者,可考虑靶向转诊进行肺功能检查以发现未诊断慢阻肺。
- 该评分可整合入临床信息系统,辅助病例发现流程。
局限性
- 研究基于英国西米德兰兹的基层医疗人群,外部推广性需进一步验证。
- 评分开发仅使用返回邮寄问卷的2398名参与者,可能存在选择偏倚。
- 外部验证样本为返回机会性问卷的1097名参与者,与开发样本的招募方式不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic obstructive pulmonary disease (COPD) is greatly underdiagnosed worldwide and more efficient methods of case-finding are required. We developed and externally validated a risk score to identify undiagnosed COPD using primary care records.We conducted a retrospective cohort analysis of a pragmatic cluster randomised controlled case-finding trial in the West Midlands, UK. Participants aged 40-79 years with no prior diagnosis of COPD received a postal or opportunistic screening questionnaire. Those reporting chronic respiratory symptoms were assessed with spirometry. COPD was defined as presence of relevant symptoms with a post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio below the lower limit of normal. A risk score was developed using logistic regression with variables available from electronic health records for 2398 participants who returned a postal questionnaire. This was externally validated among 1097 participants who returned an opportunistic questionnaire to derive the c-statistic, and the sensitivity and specificity of cut-points.A risk score containing age, smoking status, dyspnoea, prescriptions of salbutamol and prescriptions of antibiotics discriminated between patients with and without undiagnosed COPD (c-statistic 0.74, 95% CI 0.68-0.80). A cut-point of ≥7.5% predicted risk had a sensitivity of 68.8% (95% CI 57.3-78.9%) and a specificity of 68.8% (95% CI 65.8.1-71.6%).A novel risk score using routine data from primary care electronic health records can identify patients at high risk for undiagnosed symptomatic COPD. This score could be integrated with clinical information systems to help primary care clinicians target patients for case-finding.
引用
- Haroon S, Adab P, Riley RD, et al. Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score. Eur Respir J. 2017. PMID: 28642308. doi:10.1183/13993003.02191-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。